Image Source: Pixabay

Getinge (GNGBY) manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings.

The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems.

Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Three key data points gauge Getinge or any dividend paying firm.

The key three are:

(1) Price

(2) Dividends

(3) Returns

Those three keys also best tell whether any company has made, is making, and will make money.

GNGBY Price

Over the past year, Getinge share price rose about 23% from $17.83 to $21.90 as of Friday’s market close. In the past thirty years the company’s share price has never been less than $9.00 nor higher than $48.89.

If Getinge shares trade in the range of $17.00 to $25.00 this next year, the recent $21.90 share price might reach $23.30 in a year. Of course, GNGBY price could also drop about the same $1.30 estimated amount, or more.

My $1.30 upside estimate is  $0.13 under the average Getinge 1 year price gain over the past 5 years

GNGBY Dividend

Getinge AB has paid variable annual dividends since February 2013.  The most recent $0.4025 A dividend was declared February 7th for shareholders of record April 23rd  and was paid May 14th.  A forward looking $.40 annual dividend yields 1.84% at Monday’s closing price.

GNGBY Returns

Putting it all together, a $1.70 estimated one year gross gain per share shows up when adding Getinge’s $0.40 estimated annual dividend to the estimated price upside of $1.30, making that $1.70 gross gain per share total.

A little over $1000 buys us 46 shares at the $21.90 share price.

A $10 broker fee (if charged), paid half at purchase and half at sale, might take about $0.22 per share out of the $1.70 annual estimated gross-gain to give us a net gain of $1.48 X 46 shares = $68.08 for about a 6.8% estimated net gain for the year.

However, the $18.40 annual dividend income from $1K invested is under the GNGBY single share price. By these numbers, Getinge AB may be an ideal dividend dog when its price drops to (or below) $20.00.

Then, you might choose to pounce on Getenge It is a 100 year-old annual dividend-paying Swedish-based health care equipment and supplies source with an 11 year record paying uninterrupted quarterly dividends.

The exact track of Getinge’s future price and dividend will entirely be determined by market action.

Remember the true value of any stock is best realized through personal ownership of shares.

More By This Author:

Current Report: Bristol-Meyers Squibb (BMY)
Current Report: Mercedes Benz Group
Current Report: Kingfisher